Skip to content

MIYOPERİCYTOMA OF ORAL MUCOSE: CASE REPORT

A RARE TUMOR OF THE ORAL MUCOSE, MIYOPERİCYTOMA: CASE REPORT

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05126420
Enrollment
1
Registered
2021-11-19
Start date
2020-01-01
Completion date
2021-01-01
Last updated
2021-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopericytoma

Keywords

oral pathology, mıyopericytoma

Brief summary

Miyopericytoma (MPC) is defined as a benign tumor consisting mostly of oval-spindle-shaped myoid-appearing cells with perivascular growth. It may involve a single or multiple anatomical regions and may be multifocal and tends to occur mainly in the extremities, dermal and superficial soft tissues of adults. Cases of miyopericytoma due to trauma have been reported.Histological features and clinical course are generally benign, but features suggestive of low-grade malignancy were seen in MPCs. Myopericytoma in the oral and maxillofacial region is rare and a limited number of cases have been reported in the literature. A 42-year-old female patient was admitted to our clinic with an enlarging lesion on the lingual aspect of the anterior mandible, which she noticed 2 years ago. As a result of the examination, a smooth-surfaced, off-white, pedunculated, fibrotic, painless, and non-bleeding lesion was detected in the lingual aspect of the anterior mandible. The lesion was removed by excisional biopsy.

Interventions

PROCEDUREbiopsy

biopsy to identify the lesion in the oral mucosa

Sponsors

Ankara University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

Patient with a fibrotic lesion in the mouth

Exclusion criteria

Patient without fibrotic lesions in the mouth.

Design outcomes

Primary

MeasureTime frameDescription
biopsy2 dayWe evaluated the extracted biopsy material with histological parameter.

Secondary

MeasureTime frameDescription
recurrence1 yearClinical parameter

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026